About Sobi

Sobi develops and delivers breakthrough medicines for people living with rare diseases in haematology, immunology and specialty care. The company identifies and advances innovative therapies, bridging the gap between scientific discovery and patient access to ensure treatments reach those who need them most, regardless of location. Only 5% of rare diseases have approved treatments. Sobi operates globally across Europe, North America, the Middle East, Asia and Australia, combining clinical development with commercial expertise. This enables the company to bring life changing therapies to patients faster while building partnerships that expand access and support communities affected by rare conditions.